Alvimopan-d<sub>5</sub>

Alvimopan-d5

CAT N°: 33812
Price:

913.00 776.05

Alvimopan-d5 is intended for use as an internal standard for the quantification of alvimopan (Item No. 23902) by GC- or LC-MS. Alvimopan is a ?-opioid receptor antagonist (Ki = 0.47 nM).{25494} It is selective over the ?- and ?-opioid receptors (Kis= 100 nM and 12 nM, respectively). Alvimopan inhibits ?-opioid receptor-mediated GTP binding to CHO cell membranes with an IC50 value of 1.7 nM. It inhibits morphine-induced slowing of colorectal transit in mice with an ED50 value of 0.41 mg/kg.{39510} Alvimopan (0.3 and 1 mg/kg, p.o.) reduces inhibition of gastrointestinal (GI) transit induced by morphine, but not apraclonidine (Item No. 23904), in rats. Formulations containing alvimopan have been used in the treatment of opioid-induced bowel dysfunction.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View